Andrew Reardon SEC EDGAR Filings (CIK 0001950232)

SEC EDGAR filings, ownership reports, and insider transactions for Andrew Reardon.

Business address
C/O Ligand Pharmaceuticals Incorporated, 3911 Sorrento Valley Blvd, Suite 110, San Diego, CA, 92121
Top holdings (ownership)
LGND
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Andrew Reardon has filed 25 SEC EDGAR filings since 07 Nov 2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT 12 Aug 2025 10 Aug 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 02 Jul 2025 30 Jun 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 24 Jun 2025 23 Jun 2025 001-33093
144 Open Document Open Filing 23 Jun 2025
4 Open Document Open Filing PRIMARY DOCUMENT 12 Jun 2025 10 Jun 2025 001-33093
144 Open Document Open Filing 10 Jun 2025
4 Open Document Open Filing PRIMARY DOCUMENT 02 Jun 2025 10 Aug 2024 001-33093
144 Open Document Open Filing 15 May 2025
4 Open Document Open Filing PRIMARY DOCUMENT 06 Mar 2025 04 Mar 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 19 Feb 2025 14 Feb 2025 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 25 Sep 2024 23 Sep 2024 001-33093
144 Open Document Open Filing 23 Sep 2024
4 Open Document Open Filing PRIMARY DOCUMENT 30 Aug 2024 28 Aug 2024 001-33093
144 Open Document Open Filing 28 Aug 2024
4 Open Document Open Filing PRIMARY DOCUMENT 02 Jul 2024 28 Jun 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 13 May 2024 09 May 2024 001-33093
144 Open Document Open Filing 09 May 2024
4 Open Document Open Filing PRIMARY DOCUMENT 29 Feb 2024 27 Feb 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 16 Feb 2024 15 Feb 2024 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 04 Jan 2024 29 Dec 2023 001-33093
4 Open Document Open Filing PRIMARY DOCUMENT 14 Aug 2023 10 Aug 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION 28 Mar 2023 24 Mar 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION 27 Feb 2023 23 Feb 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION 01 Dec 2022 30 Nov 2022 001-33093
3 Open Document Open Filing FORM 3 SUBMISSION 07 Nov 2022 01 Nov 2022 001-33093